Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-12-12FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOS (pioglitazone) from Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2016-12-12FDA Approved: ALOGLIPTIN AND PIOGLITAZONE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
The FDA approved a supplemental application for the fixed-dose combination of alogliptin benzoate and pioglitazone from Padagis Israel Pharm…
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: A Single-dose Cross-over Study to Assess Direct and Indirect Effects of Dapagliflozin on Pancreatic Alpha and Beta Cells in Patients With Type 2 Diabetes [Phase 4]
Phase 4 single-dose cross-over clinical trial evaluating the direct and indirect effects of dapagliflozin on pancreatic alpha and beta cells…
-
CLINICAL_TRIALS research · 2016-12-12Clinical Trial Update: Metabolomic Profiling of Novel Mediators of Vascular Function
A terminated clinical trial evaluating metabolomic mediators of vascular function in individuals with Type 2 Diabetes Mellitus.
-
FDA approval · 2016-12-09FDA Approved: SYNJARDY XR — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved SYNJARDY XR as an original application for a fixed-dose combination of empagliflozin and metformin hydrochloride (XR formul…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: The Effects of Apple Consumption on Cardiovascular Health in Prediabetics and Type 2 Diabetics [Phase 2]
Phase 2 trial evaluating the effects of apple consumption on cardiovascular health in people with prediabetes and type 2 diabetes; the study…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-8666 in Participants With Type 2 Diabetes Mellitus (MK-8666-003) [Phase 1]
Phase 1 clinical trial update evaluating safety, tolerability, pharmacodynamics, and pharmacokinetics of MK-8666 in adults with type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Can Vitamin D Supplementation Prevent Type 2 Diabetes? [Phase 4]
A Phase 4 trial sponsored by Monash University evaluating whether vitamin D supplementation can prevent Type 2 Diabetes Mellitus has complet…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: A Study of Dulaglutide (LY2189265) in Participants With Type II Diabetes [Phase 3]
Phase 3 trial update for dulaglutide in adults with type 2 diabetes; results posted after completion.
-
FDA approval · 2016-12-07FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved Metformin Hydrochloride from Macleods Pharmaceuticals Limited under an original ANDA, establishing a generic version of met…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Evaluation of Myocardial Perfusion Heterogeneity Imaging in Diabetes Patients (EVADIAB)
The EVADIAB study evaluating myocardial perfusion heterogeneity imaging in type 2 diabetes patients has completed.
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: 1.2% Rosuvastatin Subgingivally Delivered In Chronic Periodontitis With Type 2 Diabetes Mellitus [Phase 2, Phase 3]
A Phase 2/3 trial evaluated 1.2% rosuvastatin delivered subgingivally for chronic periodontitis in individuals with type 2 diabetes; the stu…
-
CLINICAL_TRIALS research · 2016-12-07Clinical Trial Update: Effects of Nutrition Meal Replacement and Individualized Exercise Prescription on Type 2 Diabetes [NA]
This clinical trial update describes a study investigating whether nutrition meal replacement plus individualized exercise prescription can …
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: An Observational Study in Type 2 Diabetic Patients on Oral Antidiabetic Drugs and Basal Insulin in Near East Countries
This document reports the completion of an observational study in patients with Type 2 diabetes mellitus in Near East countries, examining o…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using Toujeo [Phase 3]
Phase 3 trial comparing MyStar DoseCoach-guided dose titration to routine titration in adults with Type 2 Diabetes Mellitus treated with Tou…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects [Phase 2]
Phase 2 pharmacodynamic study evaluating the effect of INCB013739 on insulin sensitivity in obese individuals with type 2 diabetes; the tria…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Safety and Efficacy of EndoBarrier in Subjects With Type 2 Diabetes Who Are Obese [NA]
A terminated clinical trial evaluated the safety and efficacy of the EndoBarrier device in obese patients with type 2 diabetes; results were…
-
CLINICAL_TRIALS research · 2016-12-01Clinical Trial Update: Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes
AstraZeneca's clinical trial update identifies risk factors for low lymphocyte counts in patients with type 2 diabetes; the study has comple…
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Magnesium Treatment of Inflammation in Disorders of Glucose Homeostasis [Phase 1]
Phase 1 trial evaluating magnesium as an anti-inflammatory treatment in disorders of glucose homeostasis has completed in individuals with T…
-
CLINICAL_TRIALS trial_result · 2016-11-29Clinical Trial Update: Omega-3 Fatty Acids Supplementation and Atherothrombotic Biomarkers in Type 2 Diabetes and Cardiovascular Disease. [NA]
This clinical trial update examines omega-3 fatty acids supplementation and its effect on atherothrombotic biomarkers in individuals with Ty…
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 Diabetes [Phase 3]
Phase 3 trial results evaluate the efficacy and safety of a fixed-dose combination tablet of alogliptin and metformin in adults with Type 2 …
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Effect of Dialysis Glucose Bath on Glycemic Control in Hemodialysis (HD) [NA]
A completed clinical trial studied the effect of a dialysis glucose bath on glycemic control in adults with type 2 diabetes on hemodialysis;…
-
CLINICAL_TRIALS trial_result · 2016-11-25Clinical Trial Update: Observational Study of Patients Using Levemir® or Insulatard® as Start Insulin for Treatment of Diabetes
An observational study update examining patients who started insulin therapy with Levemir or Insulatard for diabetes; the study has complete…
-
FDA approval · 2016-11-23FDA Approved: TOUJEO — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Toujeo (insulin glargine) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM) [Phase 4]
Phase 4 trial comparing two treatment strategies in older adults with Type 2 Diabetes Mellitus has been terminated; results posted in 2016.